[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Page 59805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21396]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council provides advice on how to prevent or reduce the 
burden of Alzheimer's disease and related dementias (ADRD) on people 
with the disease and their caregivers. During the October 24, 2022 
meeting the Advisory Council will hear presentations on access to long-
term services and supports as well as end-of-life challenges for people 
living with ADRD. Federal agencies will provide updates including a 
presentation from the Administration for Community Living on the new 
National Strategy to Support Family Caregivers.

DATES: The meeting will be held on October 24, 2022 from 9:00 a.m. to 
4:30 p.m. EST.

ADDRESSES: The meeting will be a hybrid of in-person and virtual. The 
meeting will be held in Room 800 of the Hubert H. Humphrey Building, 
200 Independence Avenue SW, Washington, DC 20201. It will also stream 
live at www.hhs.gov/live.
    Comments: Time is allocated on the agenda to hear public comments 
from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited 
to two (2) minutes per individual. In order to provide a public 
comment, please register by emailing your name to [email protected] by 
Thursday, October 20. Registered commenters may provide their comments 
either in-person or virtually on Friday, October 21. Registered 
commenters attending virtually will receive both a dial-in number and a 
link to join the meeting virtually; individuals will have the choice to 
either join virtually via the link, or to call in only by using the 
dial-in number. Note: There may be a 30-45 second delay in the 
livestream video presentation of the conference. For this reason, if 
you have pre-registered to submit a public comment, it is important to 
connect to the meeting by 3:45 p.m. to ensure that you do not miss your 
name and allotted time when called. If you miss your name and allotted 
time to speak, you may not be able to make your public comment. All 
participant audio lines will be muted for the duration of the meeting 
and only unmuted by the Host at the time of the participant's public 
comment. Should you have questions during the session email 
[email protected] and someone will respond to your message as quickly as 
possible.
    In order to ensure accuracy, please submit a written copy of oral 
comments for the record by emailing [email protected] by Tuesday, October 
25. These comments will be shared on the website and reflected in the 
meeting minutes.
    In lieu of oral comments, formal written comments may be submitted 
for the record by Tuesday, October 25 to Helen Lamont, Ph.D., OASPE, 
200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments 
may also be sent to [email protected]. Those submitting written comments 
should identify themselves and any relevant organizational 
affiliations.

FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075, 
[email protected]. Note: The meeting will be available to the public 
live at www.hhs.gov/live

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. app. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: Aducanumab, dementia risk reduction, 
recommendations.
    Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's 
Project Act website when available, after the meeting.
    Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of Public 
Law 92-463, as amended (5 U.S.C. appendix 2), which sets forth 
standards for the formation and use of advisory committees.

    Dated: September 28, 2022.
Benjamin Sommers,
Senior Official Performing the Duties of the Assistant Secretary for 
Planning and Evaluation, Deputy Assistant Secretary for Health Policy.
[FR Doc. 2022-21396 Filed 9-30-22; 8:45 am]
BILLING CODE 4150-05-P